Cargando…
Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
BACKGROUND: Although the use of placebo in clinical trials of schizophrenia patients is controversial because of medical and ethical concerns, placebo-controlled clinical trials are commonly used in the licensing of new drugs. AIMS: The objective of this study was to assess the attitudes toward plac...
Autores principales: | Sugawara, Norio, Ishioka, Masamichi, Tsuchimine, Shoko, Tsuruga, Koji, Sato, Yasushi, Furukori, Hanako, Kudo, Shuhei, Tomita, Tetsu, Nakagami, Taku, Yasui-Furukori, Norio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4658191/ https://www.ncbi.nlm.nih.gov/pubmed/26600382 http://dx.doi.org/10.1371/journal.pone.0143356 |
Ejemplares similares
-
The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo, Shuhei, et al.
Publicado: (2015) -
Body mass index and quality of life among outpatients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2013) -
Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2014) -
The Influence of 5-HTTLPR Genotype on the Association between the Plasma Concentration and Therapeutic Effect of Paroxetine in Patients with Major Depressive Disorder
por: Tomita, Tetsu, et al.
Publicado: (2014) -
Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2019)